Process Development Scientist
Amgen
Summary
Join Amgen's Pre-Pivotal Drug Product Technologies organization, the Synthetics Enabling Technologies (SET) group in Cambridge, MA, as a Process Development Scientist. SET is a key Drug Product Technology interface with partners in Process Development and Research & Discovery. This individual will provide solid state characterization, with a strong focus on solid state NMR (ssNMR) spectroscopy, for drug substance and drug product process development for synthetics and biologics programs.
Job description
Key Responsibilities
- Utilize advanced solid-state characterization methods (e.g. ssNMR) to support drug substance and drug product process development for synthetics and biologics programs.
- Drive lead optimization and form selection to meet discovery research and process development requirements (Target Product Profile).
- Perform synthetics molecule assessment (developability assessment) and preclinical formulation support.
- Perform biopharmaceutical assessments utilizing predictive in silico and in vitro models to identify development strategies.
- Provide early clinical support for synthetics liquid dosage forms (e.g. drug-in-bottle, parenteral) and technical transfers to support clinical manufacturing (GMP).
- Explore and implement ssNMR techniques to enhance productivity, robustness and efficiency of small molecules and biologics development.
- Take a proactive role in developing and applying innovative ssNMR approaches, demonstrating creativity in solving complex technical problems, for example understanding excipient-drug interactions and quantitative analysis of heterogeneous mixtures.
- Provide solid state characterization support to biopharmaceutics assessment, form screening/selection, and drug substance and drug product process development for synthetics and biologics programs.
- Interface with partners in Process Development and Research and Development.
- Support departmental activities including training staff and presenting scientific results at internal/external meetings.
- Build and maintain strong working relationships with key stakeholders internally and externally.
- Contributes to regulatory filings including IND and NDA as needed and assists in answering questions from regulatory authorities.
- Contributes to Amgen's intellectual property and patent filings.
Basic Qualifications
- Doctorate degree OR Master's degree and 2 years of Scientific experience OR Bachelor's degree and 4 years of Scientific experience
Preferred Qualifications
- Master's degree in one of the following areas: Physics, Materials Science, Pharmaceutical Sciences, Chemical Engineering, Chemistry, Biochemistry, or a related scientific discipline
- Strong background in ssNMR spectroscopy method development and theory with a record of scientific presentations, such as, peer-reviewed publications
- Experience in ssNMR instrumentation, operation, and maintenance is beneficial
- Specific experience developing ssNMR methods to characterize small and large molecule drug substances and drug products, such as solid form analysis, impurity phase/amorphous content detection and physical stability assessment
- Experience in solid-state characterization (DSC, TGA, XRPD, microscopy, moisture sorption, particle characterization, etc.) is desired
- Working knowledge of solid form development such as polymorphism, solvates/hydrates and salt/co-crystal characterization is beneficial
- Good informatics skills and experience with molecular modelling calculations to study molecular interactions and simulate NMR experimental observables is beneficial
- Excellent written, verbal, and presentation skills - ability to distill, craft and present key messages relative to diverse audience requirements
- Problem solver with a proactive attitude and ability to collaborate and work in a cross-functional and multidisciplinary environment
- Abilities to take initiatives, work independently, and be flexible in responsibilities
Requirements
- Doctorate degree OR Master's degree and 2 years of Scientific experience OR Bachelor's degree and 4 years of Scientific experience
- Strong background in ssNMR spectroscopy method development and theory
- Record of scientific presentations, such as peer-reviewed publications
- Experience in ssNMR instrumentation, operation, and maintenance
- Experience developing ssNMR methods to characterize small and large molecule drug substances and drug products
- Experience in solid-state characterization (DSC, TGA, XRPD, microscopy, moisture sorption, particle characterization, etc.)
- Working knowledge of solid form development such as polymorphism, solvates/hydrates and salt/co-crystal characterization
- Good informatics skills and experience with molecular modelling calculations
- Excellent written, verbal, and presentation skills
- Problem solver with a proactive attitude and ability to collaborate in a cross-functional and multidisciplinary environment
- Abilities to take initiatives, work independently, and be flexible in responsibilities
Benefits
- Health insurance
- Dental coverage
- Vision coverage
- Retirement and savings plan
- Life insurance
- Disability insurance
- Flexible spending accounts
- Discretionary annual bonus
- Stock-based long-term incentives
- Paid time-off
Company overview
Amgen Inc. is a leading American multinational biopharmaceutical company headquartered in Thousand Oaks, California, founded in 1980. As one of the world's largest independent biotechnology companies, Amgen specializes in discovering, developing, manufacturing, and delivering innovative human therapeutics. The company focuses on six key therapeutic areas: inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience. Amgen's portfolio includes blockbuster drugs such as Enbrel for autoimmune diseases, Prolia and XGEVA for osteoporosis, Repatha for cholesterol management, Otezla for psoriasis, and Neulasta for chemotherapy-induced neutropenia. With approximately 28,000 employees worldwide, Amgen operates as a component of both the Dow Jones Industrial Average and Nasdaq-100 indices. The company maintains a robust research and development pipeline with numerous clinical programs across various stages, leveraging cutting-edge biotechnology and human genetic data to address some of the world's most challenging diseases. Amgen's manufacturing capabilities span multiple global locations, and it distributes products through pharmaceutical wholesale distributors and direct-to-consumer channels.